Mark A. Atkinson
11Patents
5h-index
18Co-inventors
63Inventor score
Filing activity: Mar 28, 1994 → Feb 14, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5645998A | Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5762937A | Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus | Physics | 10 | Expired |
| US6001360A | Method and compositions for early detection and treatment of insulin dependent diabetes mellitus | Emerging Cross-Sectional Technologies | 6 | Expired |
| US7648825B2 | Biomarkers for differentiating between type 1 and type 2 diabetes | Emerging Cross-Sectional Technologies | 6 | Active |
| US9700609B2 | Compositions for treatment and/or prevention of autoimmune disorders | Human Necessities | 5 | Active |
| US6300089A | Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus | Emerging Cross-Sectional Technologies | 5 | Expired |
| US9474773B2 | Lactobacillus supplement for alleviating type 1 diabetes | Human Necessities | 2 | Active |
| US10022440B2 | Materials and methods for modulating immune responses | Human Necessities | 2 | Active |
| US8758761B2 | Combination therapies for treating type 1 diabetes | Human Necessities | 1 | Active |
| US8594949B2 | Biomarkers for differentiating between type 1 and type 2 diabetes | Emerging Cross-Sectional Technologies | 0 | Active |
| US11567088B2 | Methods for diagnosis of type 1 diabetes | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.